A scientific breakthrough in shrimp disease detection will change the way shrimp farmers produce and manage disease risk in shrimp, helping them achieve big cost savings in the process, Australian company Genics said.
Genics says its new commercially available testing technology, Shrimp MultiPath, allows 13 pathogens of shrimp to be tested in a single assay. An assay is a procedure for measuring the biochemical or immunological activity of a sample.
Most other testing systems used by the shrimp industry are only able to test for one pathogen at a time, whereas shrimp may carry up to four at any one time, the company said.
